Compare NPCE & ITIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NPCE | ITIC |
|---|---|---|
| Founded | 1997 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.3M | 431.1M |
| IPO Year | 2021 | 1995 |
| Metric | NPCE | ITIC |
|---|---|---|
| Price | $16.54 | $240.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $18.33 | N/A |
| AVG Volume (30 Days) | ★ 152.6K | 16.3K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.38% |
| EPS Growth | ★ 29.03 | 13.02 |
| EPS | N/A | ★ 18.57 |
| Revenue | $99,986,000.00 | ★ $272,755,000.00 |
| Revenue This Year | $0.90 | N/A |
| Revenue Next Year | $24.46 | N/A |
| P/E Ratio | ★ N/A | $12.99 |
| Revenue Growth | ★ 25.13 | 5.60 |
| 52 Week Low | $7.56 | $190.20 |
| 52 Week High | $18.97 | $288.98 |
| Indicator | NPCE | ITIC |
|---|---|---|
| Relative Strength Index (RSI) | 70.46 | 66.72 |
| Support Level | $15.25 | $209.72 |
| Resistance Level | $16.96 | $248.63 |
| Average True Range (ATR) | 0.69 | 5.90 |
| MACD | 0.28 | 2.54 |
| Stochastic Oscillator | 98.43 | 93.77 |
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.